Growth hormone does not attenuate the inhibitory effects of sepsis on wound healing

Wound Repair and Regeneration

Volumn 8, Issue 2, 2000, Pages 103-109

  Stamm, Jason ^b   Cooney, Robert N ^a   Maish III, George O ^a   Shumate, Margaret L ^a   Lang, Charles H ^a   Ehrlich, H Paul ^a   Vary, Thomas C ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; POLYVINYL ALCOHOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; FOOD INTAKE; GROWTH INHIBITION; IMPLANTATION; MEDIATOR RELEASE; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; RAT; SEPSIS; SKIN INCISION; TISSUE REPAIR; WOUND HEALING;

ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GROWTH HORMONE; INJECTIONS, SUBCUTANEOUS; INSULIN-LIKE GROWTH FACTOR I; MALE; RADIOIMMUNOASSAY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; SEPSIS; SKIN; TREATMENT OUTCOME; WOUND HEALING; WOUNDS AND INJURIES;

EID: 0034007751     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-475X.2000.00103.x     Document Type: Article

References (29)

1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-55.
2. Cerra FB, Siegel JH, Coleman B, Border JR, McMenamy RR. Septic autocannibalism: A failure of exogenous nutritional support. Ann Surg 1980;192:570-80.
3. Cooney RN, Iocono J, Maish GO, Smith JS, Ehrlich P. Tumor necrosis factor mediates impaired wound healing in chronic abdominal sepsis. J Trauma 1997;42:1-6.
4. Maish GO, Shumate M, Ehrlich P, Cooney RN. Tumor necrosis factor binding protein improves incisional wound healing in sepsis. J Surg Res 1998;78:108-17.
5. Wilmore D. Catabolic illnesses: Strategies for enhancing recovery. NEJM 1991;325:695-702.
6. Thornton FJ, Schaffer MR, Barbul A. Wound healing in sepsis and trauma. Shock 1997;8:391-401.
7. Chang HR, Bistrian B. The role of cytokines in the catabolic consequences of infection and injury. J Parenter Enteral Nutr 1998;22:156-66.
8. Chang DW, DeSanti L, Demling RH. Anticatabolic and anabolic strategies in critical illness: a review of current treatment modalities. Shock 1998;10:155-60.
9. Hintz RL, Rosenfeld RG, Wilson DM, Bennet A, Finno J, McClelland B, Swift R. Biosynthetic methionyl human growth hormone is biologically active in man. Lancet 1982;1:1276-9.
10. Hollander DM, Devereux DF, Marafino BJ, Hoppe H. Increased wound breaking strength in rats following treatment with synthetic human growth hormone. Surg Forum 1985;36:612.
11. Jorgensen PH, Andreassen TT. A dose-response study of the effects of biosynthetic growth hormone on formation and strength of granulation tissue. Endocrinology 1987;121:1637-41.
12. Jorgensen PH, Andreassen TT. Influence of human growth hormone on biomechanical properties of rat skin incisional wounds. Acta Chir Scand 1988;154:523-6.
13. Jorgensen PH, Andreassen TT, Jorgensen KD. Growth hormone influences collagen deposition and mechanical strength of intact rat skin. A dose-response study. Acta Endocrinologica 1989;120:767-72.
14. Jorgensen PH, Bang C, Andreassen TT, Flyvbjerg A, Orskov H. Dose-response study of the effect of growth hormone on mechanical properties of skin graft wounds. J Surg Res 1995;58:295-301.
15. Herndon DN, Barrow RE, Kunkel KR, Broemeling L, Rutan RL. Effects of recombinant human growth hormone on donor site healing in severely burned children. Ann Surg 1990;212:424-34.
16. Fan J, Molina PE, Gelato MC, Lang CH. Differential tissue regulation of insulin-like growth factor-I content and binding protein after endotoxin. Endocrinology 1994;134:1685-92.
17. Lang CH, Fan J, Cooney RN, Vary TC. IL-1 receptor antagonist attenuates sepsis-induced alterations in the IGF system and protein synthesis. Am J Physiol 1996;270:E430-7.
18. Reddy GK, Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 1996;29:225-30.
19. Windsor JA, Knight GS, Hill GL. Wound healing response in surgical patients: Recent food intake is more important than nutritional status. Br J Surg 1988;75:135-7.
20. Dahn MS, Lange MP, Jacobs LA. Insulin-like growth factor I production is inhibited in human sepsis. Arch Surg 1988;123:1409-14.
21. Dahn MS, Lange MP. Systemic and splanchnic metabolic response to exogenous human growth hormone. Surgery 1998;123:528-38.
22. Wojnar MM, Fan J, Frost RA, Gelato MC, Lang CH. Alterations in the insulin-like growth factor system in trauma patients. Am J Physiol 1995;268:R970-7.
23. Mueller RV, Hunt TK, Tokunaga A, Spencer EM. The effect of insulin-like growth factor-I on wound healing variables and macrophages in rats. Arch Surg 1994;129:262-5.
24. Jyung RW, Mustoe TA, Busby WH, Clemmons DR. Increased wound breaking strength induced by IGF-1 in combination with IGFBP-1. Surgery 1995;115:233-9.
25. Tsuboi R, Chog-Ming S, Sato C, Cox GN, Ogawa H. Co-administration of insulin-like growth factor I and IGF-binding protein-1 stimulates wound healing in animal models. J Invest Dermatol 1995;104:199-203.
26. Mao Y, Ling PR, Fitzgibbons TP, McCowen KC, Frick GP, Bistrian BR, Smith RJ. Endotoxin-induced inhibition of growth hormone signaling in rat liver in vivo. Endocrinology 1999;140:5505-15.
27. Takal J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999;341:785-92.
28. Steenfos HH, Jansson JO. Growth hormone stimulates granulation tissue formation and insulin-like growth factor-I gene expression in wound chambers in rats. J Endocrinol 1992;132:293-8.
29. Bettany GEA, Camacho-Hubner C, Obeid O, Halliday D, Powell-Tuck J. Metabolic effects of adjuvant recombinant human growth hormone in patients with continuing sepsis receiving parenteral nutrition. J Parenter Enteral Nutr 1998;22:199-205.